Rhinology papers, talked through by the people who wrote them.
Scope It Out is the official podcast of the International Forum of Allergy and Rhinology, pairing a physician host with the authors of a paper from the journal. The questions stay close to the work: how the cohort was built, what the matching controlled for, and whether patients held on to their improvement.
PRESS PLAY
Scope It Out is the official podcast of the International Forum of Allergy and Rhinology, and its premise is narrow on purpose. Episodes are built around a single paper from the journal, with its authors in conversation with a physician host. The paper sets the agenda. The host changes from episode to episode: Dr. Christine Smith of Salt Lake City, Dr. Doug Ray of Baltimore, Dr. Amber Luong of McGovern Medical School in Houston and Dr. Dan Beswick of Los Angeles each lead episodes in this run. What a listener gets is the reasoning a journal abstract has to compress. Dr. Jamie Oliver and Dr. Jennifer Vilwock explain why an observational study of systemic estrogen therapy and nasal obstruction surgery called for propensity score matching, then list what the groups were matched on, from age and race to polyps, rhinitis and asthma. Dr. Ed Kwan and Dr. Alan Workman talk through an American Rhinologic Society expert practice statement on surveillance after sinonasal malignancy, including a recommendation of at least five years of follow-up even for patients without symptoms, because so many recurrences arrive silently. Workman turns up in two of these episodes. That streak earns a joking mention of a record. With Dr. Jim Palmer, he joins Dr. Luong to discuss a completeness-of-surgery index for chronic rhinosinusitis with nasal polyps and asthma, tracked by SNOT-22 and the Asthma Control Test, and the case that complete surgery, not just any surgery, is what matters. Dr. Beswick talks with Dr. Waleed Abouzid of the University of Washington about predicting surgical outcomes from preoperative data with machine learning, and about the prospective clinic database, built on REDCap, that feeds that kind of work. Mr. James Bates of the Buckinghamshire NHS Healthcare Trust reports a phase 1 trial of a botulinum toxin type A nasal spray for rhinitis in which no patient had an adverse event. Dr. Mas Takashima of Houston Methodist walks through three-year outcomes of posterior nasal nerve ablation, where roughly four in five patients kept a meaningful improvement, and offers a mechanism for why the benefit plateaued without fading. The hosts do real work. They ask for results in plain terms, press on mechanism and sometimes pause so a guest can explain a method for the audience. Acronyms such as SNOT-22 and RTNSS still pass with little translation, so the vocabulary assumes comfort with clinical research. The tone is warm and collegial. Hosts congratulate authors and co-authors, and the talk near the close turns to practice, from what a postoperative CT scan teaches a surgeon about where they did not reach to how research can be aimed at patient care. Across this run the format holds steady, and that steadiness is the appeal: rhinology research, explained by the people who produced it.
Made for: Suits a listener who treats or studies sinus and nasal disease and wants the methods and findings behind journal papers explained by their authors. Also fits anyone comfortable with clinical research vocabulary who would rather hear one study examined in depth than a broad survey of the field.
What sets it apart: Because it is the journal's own podcast, each conversation stays anchored to a single published paper, with the authors answering questions on study design, statistics and how long results last. The host changes from episode to episode, which brings different clinical viewpoints to the questioning.
Scope It Out with Dr. Tim Smith is a podcast series exploring methods and breakthroughs in the fields of allergy and rhinology and select articles from International Forum of Allergy and Rhinology.
A post-op CT scan as a surgeon's humility lesson, if you like your evidence with self-scrutiny.
Press play if you want
Short reviews from the PlayNext desk, based on the episodes we processed.
A grounded look at how hormone-related nasal patterns become an observational research question.
Scope It Out takes a timely clinical question and keeps it grounded: what role might sex hormones play in nasal physiology? Dr. Christine Smith guides Dr. Jamie Oliver and Dr.
Specialist surveillance guidance becomes practical listening for clinicians managing sinonasal malignancies.
Scope It Out turns an American Rhinologic Society Expert Practice Statement into a practical conversation about surveillance after treatment for sinonasal malignancy.
A practical review of measuring sinus surgery completeness with SNOT-22 and Asthma Control Test results.
Scope It Out gives sinus surgery a practical yardstick as Dr. Amber Luong asks Drs. Alan Workman and Jim Palmer how the Completeness of Surgery Index can describe how complete an operation was and where it might fit clinically.
A clear, methodical look at the data systems, model comparisons, and collaborations shaping AI-assisted surgical prediction.
Scope It Out looks at how preoperative patient data could help predict surgical outcomes in chronic rhinosinusitis, with Dr. Waleed Abouzid's team publication giving the episode its center of gravity.
A clear, measured review of early rhinitis safety findings and the stronger placebo-controlled evidence still needed.
Rhinitis gets a compact dose of high-tech curiosity in this single-episode review of a phase one study testing intranasal botulinum toxin type A spray. Dr. Christine Smith speaks with Mr.
A focused review of why radiofrequency treatment for chronic rhinitis may keep helping over three years.
Scope It Out looks at three-year outcomes after temperature-controlled radiofrequency ablation of the posterior nasal nerve for chronic rhinitis. Guest host Dr.
Oncology evidence translated into clinical decisions.
Critical care evidence, carefully talked through.
Clinical research, reduced to its practical signal.
Scope It Out discusses a fall 2025 research note, "Systemic Estrogen Therapy Is Associated with Lower Surgical Intervention Rates for Nasal Obstruction," with host Dr.
Scope It Out focuses on the American Rhinologic Society Expert Practice Statement on surveillance strategies for sinonasal malignancy, introduced by Dr.
Scope It Out episode 108 focuses on the Completeness of Surgery Index, or COSI, a CT-based score built by Drs.
Scope It Out episode 107 centers on a University of Washington machine-learning paper that uses 59 preoperative variables from 242 chronic rhinosinusitis patients to predict whether endoscopic sinus surgery will produce a 9-point SNOT-22 improvement.
Scope It Out episode 106 centers on James Bates's phase one trial of intranasal botulinum toxin type A spray for rhinitis, run in 14 treated patients after one polypharmacy exclusion.
Scope It Out host Dr.
Scope It Out hosts Amber Luong, William Lee, and Joe Reimer discuss a systematic review and meta-analysis of systemic bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia.
Host Dan Beswick interviews Drs.
Scope It Out host Dr.
Scope It Out host Dr.
Scope It Out host Dr.
Scope It Out examines the January 2025 paper on the Completion of Surgery Index, a 100-point CT-based measure for surgical extent in chronic rhinosinusitis with nasal polyposis.
Scope It Out host Dr.
Scope It Out examines Matthew Geltziler’s study of dupilumab use and symptom severity after revision Draf 3 frontal sinusotomy for chronic rhinosinusitis with nasal polyps.
Scope It Out host Dr.
Dr.
Scope It Out host Dr.
Scope It Out host Dr.
Scope It Out host Dr.
Scope It Out examines ICAR Sinonasal Tumors 2024, a February 2024 consensus document assembled by about 450 authors across more than 400 pages.
Scope It Out host Dr.
Scope It Out host Mark Dubin interviews Dr.
Scope It Out host Dr.
Scope It Out host Dr.
Scope It Out examines the clinical letter “Left on Your Own” about left-handedness among rhinologists and otolaryngology trainees.
Dr.
Dr.